Portada del sitio > English > Global > Common Dreams | News & Views
Breaking News & Views for the Progressive Community
Artículos
-
Friends of the Earth Statement on House Republican and Senate Democrat Farm Bill Proposals
1ro de mayo, puesto en línea por Newswire EditorAfter months of delay, House Republicans and Senate Democrats unveiled dueling Farm Bill priorities today. The House’s bill slashes nutrition programs and climate-focused conservation funding in order to boost commodity crop production. It also includes the EATS Act, which is opposed by 200 (…) -
House Republicans Establish Dangerous Farm Bill Priorities
1ro de mayo, puesto en línea por Newswire EditorUnder fire for unreasonable delay, House Republicans and Senate Democrats released Farm Bill priorities today, teeing up lengthy debate on the seminal food and agriculture legislative package that is already months overdue. Early reporting suggests House Republican support for a number of (…) -
Biden’s DEA Proposes to Reschedule Marijuana Rather than Decriminalize It, Advocates Say Marijuana Must Be Descheduled
30 de abril, puesto en línea por Newswire EditorToday, the Associated Press reported that the Drug Enforcement Administration (DEA) is proposing rescheduling marijuana from a Schedule I drug, the most restrictive class, to a Schedule III drug, a less restrictive class. Under this proposed shift, marijuana criminalization would continue at the (…) -
Sanders Responds to FTC’s Efforts to Target ‘Junk’ Ozempic Patents
30 de abril, puesto en línea por Newswire EditorSen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released the following statement after Federal Trade Commission (FTC) Chair Lina Khan announced that the FTC is taking action against the bogus patents Novo Nordisk filed to keep (…) -
FTC Right to Challenge Junk Patent Listings
30 de abril, puesto en línea por Newswire EditorToday, the Federal Trade Commission (FTC) sent warning letters to 10 drug manufacturers challenging the “junk listings” of more than 300 patents in the FDA Orange Book for medicines treating diabetes, weight loss, asthma, and COPD. These letters follow FTC challenges to improper Orange Book (…)